MENU
+Compare
HART
ETF ticker: NYSE ARCA
AS OF
Jul 17, 03:01 PM (EDT)
Price
$29.62
Change
-$0.39 (-1.30%)
Net Assets
8.88M

HART stock forecast, quote, news & analysis

The investment seeks investment results that correspond generally to the price and yield performance of its underlying index, the NYLI Candriam Healthy Hearts Index... Show more

Category: #Health
HART
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for HART with price predictions
Jul 18, 2025

Aroon Indicator for HART shows an upward move is likely

HART's Aroon Indicator triggered a bullish signal on July 03, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 247 similar instances where the Aroon Indicator showed a similar pattern. In of the 247 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

HART moved above its 50-day moving average on July 16, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HART advanced for three days, in of 293 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for HART moved out of overbought territory on July 03, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on July 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on HART as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for HART turned negative on July 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HART declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HART broke above its upper Bollinger Band on June 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOGL), Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), AstraZeneca PLC (NASDAQ:AZN), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Nike (NYSE:NKE), Elevance Health (NYSE:ELV), Medtronic plc (NYSE:MDT).

Industry description

The investment seeks investment results that correspond generally to the price and yield performance of its underlying index, the NYLI Candriam Healthy Hearts Index. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the index, which was developed by IndexIQ LLC with Candriam acting as index consultant to IndexIQ. The index includes securities of large-, mid- and small-capitalization companies that trade in the U.S. and foreign markets, including emerging markets other than China, Egypt, India, Kuwait, Pakistan, Qatar, Saudi Arabia and United Arab Emirates. It is non-diversified.

Market Cap

The average market capitalization across the NYLI Healthy Hearts ETF ETF is 165.59B. The market cap for tickers in the group ranges from 3.51M to 2.62T. AAPL holds the highest valuation in this group at 2.62T. The lowest valued company is NOVN at 3.51M.

High and low price notable news

The average weekly price growth across all stocks in the NYLI Healthy Hearts ETF ETF was -1%. For the same ETF, the average monthly price growth was -1%, and the average quarterly price growth was -3%. GRMN experienced the highest price growth at 6%, while ELV experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the NYLI Healthy Hearts ETF ETF was 8%. For the same stocks of the ETF, the average monthly volume growth was 13% and the average quarterly volume growth was 7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 60
Price Growth Rating: 51
SMR Rating: 54
Profit Risk Rating: 61
Seasonality Score: 31 (-100 ... +100)
View a ticker or compare two or three
HART
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
800 Westchester Avenue,Suite N611Rye Brook
Phone
1-888-934-0777
Web
www.indexiq.com